Droperidol Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 2.5 mg/mL , 5 mg/mL
Reference Brands: Droleptan (EU)
Category:
Anaesthetics
Droperidol is available in Injection
and strengths such as 2.5 mg/mL , 5 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Droperidol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Droperidol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Droperidol is an antidopaminergic medication belonging to the butyrophenone class, widely used for its antiemetic, sedative, and antipsychotic properties. It is primarily indicated for the prevention and treatment of nausea and vomiting, particularly in postoperative and chemotherapy-related settings, and has demonstrated effectiveness comparable to ondansetron and superior to metoclopramide in several clinical uses. Droperidol is also utilized in anesthesia and intensive care units as a rapid-acting sedative, especially in situations involving severe agitation, aggression, or violent behavior.
In psychiatric and emergency care, droperidol has been administered intramuscularly in doses typically ranging from 5 to 10 mg for the management of acute psychosis in patients who refuse oral medication. However, in many regions, its role in intramuscular sedation has been largely replaced by newer agents such as haloperidol and olanzapine. Additionally, low-dose intravenous droperidol (0.5–1 mg) has been used off-label for the treatment of vertigo in elderly patients who do not respond to repositioning maneuvers like the Epley technique.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing